Cytolethal distending toxin promotes epithelial-to-mesenchymal transition by modulating AKT-dependent β-catenin Ser552 phosphorylation
PLOS Pathogens · 17.11.2026 · 22 (11) · e1014326
DOI: 10.1371/journal.ppat.1014326 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 17.11.2026. Verfasst von Ruxue Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Bordeaux, BoRdeaux Institute of onCology-BRIC, INSERM UMR1312, Bordeaux, France. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, Gironde, France, INSERM, University of Bordeaux.
Abstract (Originalsprache)
Bacterial genotoxins, Cytolethal Distending Toxin (CDT) and colibactin, cause DNA damage in intoxicated epithelial cells of the host. DNA damage influences β‑catenin signaling, altering its stability and nuclear translocation, potentially contributing to cancer development. Using non-transformed hepatocytes and cancer-derived intestinal and hepatic epithelial cell lines, we showed that CDT/CdtB induces the phosphorylation of β‑catenin at serine 552, along with the loss of β‑catenin from adherens junctions. This leads to the subsequent cytoplasmic accumulation and nuclear translocation of β‑catenin, ultimately driving TCF/LEF transcription, the crucial downstream event of Wnt/β‑catenin signaling, as well as the transcription of some β‑catenin target genes. Colibactin induces similar effects. MK‑2206, a direct AKT inhibitor, and metformin, a common diabetes drug that indirectly inhibits AKT, both protected cells against various effects induced by CdtB exposure. These effects include β‑catenin phosphorylation at Ser552, the disassembly of cell-cell junctions and the subsequent nuclear accumulation of phosphorylated β‑catenin, leading to enhanced TCF/LEF-mediated transcription—early molecular shifts driving the epithelial–mesenchymal transition (EMT). Specifically, both drugs protected against CdtB-induced EMT features, including increased nuclear accumulation of SNAIL, enhanced matrix degradation, and motility. Overall, these data show that infection with genotoxin-producing bacteria promotes key EMT features through β‑catenin and AKT-dependent signaling.
Autor:innen und Institutionen
- Univ. Bordeaux, BoRdeaux Institute of onCology-BRIC, INSERM UMR1312, Bordeaux, France.
- Univ. Bordeaux, UFR des Sciences Médicales, Bordeaux, France.
- CHU de Bordeaux, Institut de Pathologie et de Biologie du Cancer, Bordeaux, France.
ORCID-Profile: Armelle Ménard
Förderung
- Ligue Contre le Cancer, Gironde, France
- INSERM
- University of Bordeaux
- China Scholarship Council
- French Ministry of Higher Education and Research
Zitieren
APA
Jia, R., Azzi-Martin, L., Saraiva, M., Sifré, E., Varon, C., Dubus, P., & Ménard, A. (2026). Cytolethal distending toxin promotes epithelial-to-mesenchymal transition by modulating AKT-dependent β-catenin Ser552 phosphorylation. PLOS Pathogens, 22(11), e1014326. https://doi.org/10.1371/journal.ppat.1014326
Vancouver
Jia R, Azzi-Martin L, Saraiva M, Sifré E, Varon C, Dubus P, et al. Cytolethal distending toxin promotes epithelial-to-mesenchymal transition by modulating AKT-dependent β-catenin Ser552 phosphorylation. PLOS Pathogens. 2026;22(11):e1014326. doi:10.1371/journal.ppat.1014326
BibTeX
@article{Jia2026,
author = {Jia, Ruxue and Azzi-Martin, Lamia and Saraiva, Mariana and Sifré, Elodie and Varon, Christine and Dubus, Pierre and Ménard, Armelle},
title = {Cytolethal distending toxin promotes epithelial-to-mesenchymal transition by modulating AKT-dependent β-catenin Ser552 phosphorylation},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {11},
pages = {e1014326},
doi = {10.1371/journal.ppat.1014326}
}
EUVIMED